212 related articles for article (PubMed ID: 28002471)
1. Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach.
Kaguelidou F; Alberti C; Biran V; Bourdon O; Farnoux C; Zohar S; Jacqz-Aigrain E
PLoS One; 2016; 11(12):e0166207. PubMed ID: 28002471
[TBL] [Abstract][Full Text] [Related]
2. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
Bishop J; Furman M; Thomson M
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
[TBL] [Abstract][Full Text] [Related]
5. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
[TBL] [Abstract][Full Text] [Related]
6. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
[TBL] [Abstract][Full Text] [Related]
7. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease.
Omari T; Lundborg P; Sandström M; Bondarov P; Fjellman M; Haslam R; Davidson G
J Pediatr; 2009 Aug; 155(2):222-8. PubMed ID: 19394048
[TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.
Springer M; Atkinson S; North J; Raanan M
Paediatr Drugs; 2008; 10(4):255-63. PubMed ID: 18590344
[TBL] [Abstract][Full Text] [Related]
10. Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms.
Poelmans J; Feenstra L; Tack J
Dig Dis Sci; 2006 Feb; 51(2):282-8. PubMed ID: 16534670
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
[TBL] [Abstract][Full Text] [Related]
12. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Miner P; Katz PO; Chen Y; Sostek M
Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
[TBL] [Abstract][Full Text] [Related]
13. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
15. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
16. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease?
Hendel J; Hendel L; Aggestrup S
Aliment Pharmacol Ther; 1995 Dec; 9(6):693-7. PubMed ID: 8824658
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH.
Garcia RS; Belafsky PC; Della Maggiore A; Osborn JM; Pypendop BH; Pierce T; Walker VJ; Fulton A; Marks SL
J Vet Intern Med; 2017 May; 31(3):734-742. PubMed ID: 28425145
[TBL] [Abstract][Full Text] [Related]
18. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole.
Kiljander TO; Salomaa ER; Hietanen EK; Terho EO
Chest; 1999 Nov; 116(5):1257-64. PubMed ID: 10559084
[TBL] [Abstract][Full Text] [Related]
20. [Omeprazole of limited value in crying babies].
Blokpoel RG; Broos N; de Jong-van den Berg LT; de Vries TW
Ned Tijdschr Geneeskd; 2010; 154():A1850. PubMed ID: 20719016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
